STAAR Surgical Company
STAA
$18.93
$0.090.48%
NASDAQ
| 01/02/2026 | 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | |
|---|---|---|---|---|---|
| Net Income | -306.09% | 152.84% | 68.99% | -58.38% | -442.97% |
| Total Depreciation and Amortization | 0.35% | 1.27% | -15.49% | -1.60% | 35.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.02% | 553.26% | -79.36% | 112.16% | -30.55% |
| Change in Net Operating Assets | 103.00% | -94.03% | -153.96% | 19.50% | 227.62% |
| Cash from Operations | -246.76% | 109.79% | -375.22% | -993.15% | -83.18% |
| Capital Expenditure | -89.92% | 50.73% | -22.07% | 74.36% | 8.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -387.67% | -77.09% | -26.91% | 367.39% | 52.53% |
| Cash from Investing | -467.50% | -78.97% | -28.94% | 281.33% | 44.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -2.44% | 2.38% |
| Issuance of Common Stock | -96.16% | 24,608.33% | -96.82% | 842.50% | -97.59% |
| Repurchase of Common Stock | 91.73% | 56.46% | -254.79% | -1,077.06% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -105.09% | 121.65% | -378.90% | -761.82% | -106.81% |
| Foreign Exchange rate Adjustments | 310.99% | -86.73% | 139.86% | 132.46% | -184.96% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -354.93% | 250.83% | -120.66% | 245.91% | 31.03% |